US2965643A
(en)
|
|
1960-12-20 |
|
Derivatives of pyrazolo |
US2858309A
(en)
|
1956-05-07 |
1958-10-28 |
Ciba Pharm Prod Inc |
New aminobenzene sulfonamide
|
US3546295A
(en)
|
1968-08-01 |
1970-12-08 |
Exxon Research Engineering Co |
N-cycloalkyl anilines
|
IT8124760A0
(it)
|
1980-10-29 |
1981-10-29 |
Nippon Kayaku Kk |
Derivati di 5,6,7,8-tetraidro-1,6-naftiridina e procedimento per la loro preparazione.
|
JPH01104052A
(ja)
|
1987-06-12 |
1989-04-21 |
Yoshitomi Pharmaceut Ind Ltd |
ピリジン誘導体
|
ES2058288T3
(es)
|
1987-07-08 |
1994-11-01 |
American Home Prod |
Composiciones de ibuprofen secadas por atomizacion.
|
US5474989A
(en)
|
1988-11-11 |
1995-12-12 |
Kurita Water Industries, Ltd. |
Drug composition
|
US5260331A
(en)
|
1989-01-02 |
1993-11-09 |
John Wyeth & Brother Limited |
Composition for treating depression with (S- or O-heteroaryl)alkyl amines
|
US5422355A
(en)
|
1989-06-02 |
1995-06-06 |
John Wyeth & Brother, Limited |
Composition for treating depression with (N-heteroaryl)alkylamines
|
AU641394B2
(en)
|
1989-06-02 |
1993-09-23 |
John Wyeth & Brother Limited |
Amines
|
ES2111065T5
(es)
|
1991-04-16 |
2005-06-16 |
Nippon Shinyaku Company, Limited |
Procedimiento para producir una dispersion solida.
|
WO1993000332A1
(en)
|
1991-06-25 |
1993-01-07 |
Merck & Co., Inc. |
Substituted azetidinones as anti-inflammatory and antidegenerative agents
|
US5348953A
(en)
|
1991-06-25 |
1994-09-20 |
Merck & Co., Inc. |
Substituted azetidinones as anti-inflammatory and antidegenerative agents
|
TW225469B
(es)
|
1991-11-12 |
1994-06-21 |
Nissan Kagakl Kogyo |
|
FR2686339B1
(fr)
|
1992-01-22 |
1994-03-11 |
Adir Cie |
Nouveaux amides et sulfonamides naphtaleniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
|
DE69315920T2
(de)
|
1992-09-04 |
1998-06-10 |
Takeda Chemical Industries Ltd |
Kondensierte heterozyklische Verbindungen, deren Herstellung und Verwendung
|
EP0585500A1
(en)
|
1992-09-04 |
1994-03-09 |
Merrell Dow Pharmaceuticals Inc. |
Diaryl piperazineacetamides as antimuscarinic agents
|
MY131441A
(en)
|
1992-12-29 |
2007-08-30 |
American Cyanamid Co |
Amidrazones and their use as insecticidal and acaricidal agents
|
PL180081B1
(pl)
|
1993-08-12 |
2000-12-29 |
Astra Ab |
Nowe pochodne amidyny i sposób ich wytwarzania PL PL PL PL PL PL PL
|
US5491152A
(en)
|
1994-03-23 |
1996-02-13 |
The Du Pont Merck Pharmaceutical Company |
Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis
|
JPH07285962A
(ja)
|
1994-04-20 |
1995-10-31 |
Nissan Chem Ind Ltd |
ピリジンカルボン酸アミド誘導体
|
IT1270615B
(it)
|
1994-07-14 |
1997-05-07 |
Smithkline Beecham Farma |
Uso di derivati di chinolina
|
JPH0892224A
(ja)
|
1994-09-16 |
1996-04-09 |
Kumiai Chem Ind Co Ltd |
3,5−置換フェニルトリアゾール誘導体および殺虫、殺ダニ剤
|
JPH0892225A
(ja)
|
1994-09-29 |
1996-04-09 |
Nissan Chem Ind Ltd |
トリアゾールグリコール酸アミド誘導体
|
WO1996016650A1
(fr)
|
1994-11-29 |
1996-06-06 |
Hisamitsu Pharmaceutical Co., Inc. |
Antibacterien et bactericide comprenant un derive de 2-aminothiazole et sels de ce derive
|
GB9511220D0
(en)
|
1995-06-02 |
1995-07-26 |
Glaxo Group Ltd |
Solid dispersions
|
US6730679B1
(en)
|
1996-03-22 |
2004-05-04 |
Smithkline Beecham Corporation |
Pharmaceutical formulations
|
DE19615262A1
(de)
|
1996-04-18 |
1997-10-23 |
Bayer Ag |
Heteroverknüpfte Phenylglycinolamide
|
DE69726729T2
(de)
|
1996-05-20 |
2004-12-02 |
Janssen Pharmaceutica N.V. |
Fungizide mittel mit verbesserter bioverfügbarkeit
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
DE19636150A1
(de)
|
1996-09-06 |
1998-03-12 |
Asta Medica Ag |
N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung
|
TW523506B
(en)
|
1996-12-18 |
2003-03-11 |
Ono Pharmaceutical Co |
Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
|
AU7688398A
(en)
|
1997-06-16 |
1999-01-04 |
American Home Products Corporation |
Elevation of hdl cholesterol by 2-{(aminothioxomethyl)-hydrazono}-2-arylethyl carbamates
|
US6008362A
(en)
|
1997-06-16 |
1999-12-28 |
Commons; Thomas Joseph |
Elevation of HDL cholesterol by 2-(-4-chlorol-1-aryl-butylidene)-hydrazinecarbothioamides
|
US5977170A
(en)
|
1997-06-16 |
1999-11-02 |
American Home Products Corporation |
Elevation of HDL cholesterol by 4-[(aminothioxomethyl)hydrazono]-4-arylbutyl carbamates
|
WO1998057927A1
(en)
|
1997-06-16 |
1998-12-23 |
American Home Products Corporation |
Elevation of hdl cholesterol by 4-[(aminothioxomethyl)hydrazono]-4-arylbutyl carbamates
|
AU7589598A
(en)
|
1997-06-16 |
1999-01-04 |
American Home Products Corporation |
Elevation of hdl cholesterol by 2-(4-chloro -1-aryl-butylidene) -hydrazinecarbothioamides
|
EP1745774A3
(en)
|
1997-08-11 |
2007-04-11 |
Pfizer Products Inc. |
Solid pharmaceutical dispersions with enhanced bioavailability
|
UA67754C2
(uk)
|
1997-10-10 |
2004-07-15 |
Пфайзер, Інк. |
Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
|
JPH11209366A
(ja)
|
1998-01-23 |
1999-08-03 |
Nissan Chem Ind Ltd |
クロマン誘導体及び心不全治療薬
|
DE19814838C2
(de)
|
1998-04-02 |
2001-01-18 |
Asta Medica Ag |
Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
|
US6121271A
(en)
|
1998-05-12 |
2000-09-19 |
American Home Products Corporation |
Naphtho[2,3-B]heteroar-4-yl derivatives
|
GT199900147A
(es)
|
1998-09-17 |
1999-09-06 |
|
1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
|
US6350786B1
(en)
|
1998-09-22 |
2002-02-26 |
Hoffmann-La Roche Inc. |
Stable complexes of poorly soluble compounds in ionic polymers
|
DE19845202A1
(de)
|
1998-10-01 |
2000-04-06 |
Wella Ag |
Haarwuchsmittel
|
KR100602725B1
(ko)
|
1998-12-11 |
2006-07-20 |
파마솔루션스, 인코포레이티드 |
물에서 불충분하게 용해되는 약제를 위한 자가-유화용조성물
|
EP1970052A2
(en)
|
1999-02-09 |
2008-09-17 |
Pfizer Products Inc. |
Basic drug compositions with enhanced bioavailability
|
WO2000050398A2
(en)
|
1999-02-24 |
2000-08-31 |
F. Hoffmann-La Roche Ag |
Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
|
ES2284506T3
(es)
|
1999-06-23 |
2007-11-16 |
Syngenta Participations Ag |
Metodo de producir tiametoxam.
|
DE19930075A1
(de)
|
1999-06-30 |
2001-01-04 |
Bayer Ag |
Neue Amino- und Amidosulfonamide als antivirale Mittel
|
US6479552B2
(en)
|
1999-09-23 |
2002-11-12 |
G.D. Searle & Co. |
Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
|
TWI269654B
(en)
|
1999-09-28 |
2007-01-01 |
Baxter Healthcare Sa |
N-substituted indole-3-glyoxylamide compounds having anti-tumor action
|
IL139941A0
(en)
|
1999-12-02 |
2002-02-10 |
Pfizer Prod Inc |
Use of prostaglandin agonists to treat erectile dysfunction or impotence
|
DE60020732T2
(de)
|
1999-12-20 |
2006-05-11 |
Kerkhof, Nicholas J., Rio Vista |
Verfahren zur herstellung von nanometer partikeln durch fliessbett- sprühtrocknung
|
DE19962300A1
(de)
|
1999-12-23 |
2001-06-28 |
Asta Medica Ag |
Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
|
US6306911B1
(en)
|
2000-02-07 |
2001-10-23 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted amino acids as neutral sphingomyelinase inhibitors
|
WO2001060369A1
(en)
|
2000-02-18 |
2001-08-23 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
AU2001238424A1
(en)
|
2000-02-18 |
2001-08-27 |
Merck And Co., Inc. |
Inhibitors of prenyl-protein transferase
|
DE10023484A1
(de)
|
2000-05-09 |
2001-11-22 |
Schering Ag |
Anthranylamide und deren Verwendung als Arzneimittel
|
EP1302201A4
(en)
|
2000-07-17 |
2007-09-05 |
Astellas Pharma Inc |
PHARMACEUTICAL COMPOSITION WITH IMPROVED ABSORBABILITY
|
US7115279B2
(en)
|
2000-08-03 |
2006-10-03 |
Curatolo William J |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
|
US6576644B2
(en)
|
2000-09-06 |
2003-06-10 |
Bristol-Myers Squibb Co. |
Quinoline inhibitors of cGMP phosphodiesterase
|
WO2002022584A1
(en)
|
2000-09-11 |
2002-03-21 |
Merck & Co., Inc. |
Thrombin inhibitors
|
WO2002042273A2
(en)
|
2000-11-07 |
2002-05-30 |
Bristol-Myers Squibb Company |
Acid derivatives useful as serine protease inhibitors
|
US6869617B2
(en)
|
2000-12-22 |
2005-03-22 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
ES2292830T3
(es)
|
2001-02-21 |
2008-03-16 |
Astrazeneca Ab |
Compuestos heteropoliciclicos y su uso como antagonistas del receptor metabotropico de glutamato.
|
DE10110749A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituierte Aminodicarbonsäurederivate
|
US7034013B2
(en)
|
2001-03-20 |
2006-04-25 |
Cydex, Inc. |
Formulations containing propofol and a sulfoalkyl ether cyclodextrin
|
WO2002090349A1
(de)
|
2001-05-08 |
2002-11-14 |
Schering Aktiengesellschaft |
N-oxidanthranylamid-derivate und deren verwendung als arzneimittel
|
CZ20033341A3
(cs)
|
2001-06-21 |
2004-10-13 |
Pfizeráproductsáinc |
Samoemulgující se kompozice inhibitorů přenosového proteinu cholesterylesteru
|
KR100759635B1
(ko)
|
2001-06-22 |
2007-09-17 |
화이자 프로덕츠 인코포레이티드 |
비정질 약물의 흡착체의 약학 조성물
|
WO2003000226A2
(en)
|
2001-06-22 |
2003-01-03 |
Pfizer Products Inc. |
Pharmaceutical compositions containing polymer and drug assemblies
|
EP1269994A3
(en)
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising drug and concentration-enhancing polymers
|
ATE361758T1
(de)
|
2001-06-22 |
2007-06-15 |
Pfizer Prod Inc |
Pharmazeutische zusammensetzungen enthaltend eine feste dispersion eines im wasser schwerlöslichen arzneimittels und ein löslichkeitsteigerndes polymer
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
US6713499B2
(en)
|
2001-12-12 |
2004-03-30 |
Hoffman-La Roche Inc. |
7-Amino-benzothiazole derivatives
|
DE60322665D1
(de)
|
2002-02-01 |
2008-09-18 |
Pfizer Prod Inc |
Pharmazeutische darreichungsform mit gesteuerter freigabe eines cholesterylester-transferproteininhibitors
|
AR038375A1
(es)
|
2002-02-01 |
2005-01-12 |
Pfizer Prod Inc |
Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
|
GB0208280D0
(en)
|
2002-04-10 |
2002-05-22 |
Glaxo Group Ltd |
Novel compounds
|
US20040053842A1
(en)
|
2002-07-02 |
2004-03-18 |
Pfizer Inc. |
Methods of treatment with CETP inhibitors and antihypertensive agents
|
US7071210B2
(en)
|
2002-07-02 |
2006-07-04 |
Pfizer Inc. |
CETP inhibitors in combination with antihypertensive agents and uses thereof
|
PT1533292E
(pt)
|
2002-08-30 |
2007-05-31 |
Japan Tobacco Inc |
Compostos de dibenzilamina e sua utilização farmacêutica.
|
MXPA05005813A
(es)
|
2002-12-20 |
2005-12-12 |
Pfizer Prod Inc |
Formas de dosificacion que comprenden un inhibidor de la cetp y un inhibidor de la hmg-coa reductasa.
|
GB0303683D0
(en)
|
2003-02-18 |
2003-03-19 |
Prolysis Ltd |
Antimicrobial agents
|
EP1603879A2
(en)
|
2003-02-28 |
2005-12-14 |
Bayer Pharmaceuticals Corporation |
Substituted pyridine derivatives useful in the treatment of cancer and other disorders
|
AU2004216898A1
(en)
|
2003-03-04 |
2004-09-16 |
Pfizer Products Inc. |
Use of EP2 selective receptor agonists in medical treatment
|
WO2005000811A1
(en)
|
2003-06-11 |
2005-01-06 |
Eli Lilly And Company |
3-aminopyrrolidines as inhibitors of monoamine uptake
|
MXPA06001506A
(es)
|
2003-08-04 |
2006-05-15 |
Pfizer Prod Inc |
Formas de dosificacion de inhibidores de la proteina de transferencia de colesteril ester e inhibidores de la hmg-coa reductasa.
|
CA2536461A1
(en)
|
2003-08-27 |
2005-03-10 |
Janssen Pharmaceutica, N.V. |
Aryl piperidine amides
|
KR20070087197A
(ko)
|
2003-09-26 |
2007-08-27 |
니뽄 다바코 산교 가부시키가이샤 |
잔여 리포프로테인 생산 저해 방법
|
DE602005014955D1
(de)
|
2004-03-26 |
2009-07-30 |
Lilly Co Eli |
Verbindungen und verfahren zur behandlung von dyslipidämie
|
UA90269C2
(ru)
|
2004-04-02 |
2010-04-26 |
Мицубиси Танабе Фарма Корпорейшн |
Тетрагидрохинолиновые производные и способ их получения
|
MY139887A
(en)
|
2004-04-02 |
2009-11-30 |
Mitsubishi Tanabe Pharma Corp |
Tetrahydronaphthyridine derivatives and a process for preparing the same.
|
CA2562082C
(en)
|
2004-04-13 |
2013-06-25 |
Merck & Co., Inc. |
Cetp inhibitors for the treatment and prevention of atherosclerosis
|
WO2006056854A1
(en)
|
2004-11-23 |
2006-06-01 |
Pfizer Products Inc. |
Dibenzyl amine compounds and derivatives
|
US8604055B2
(en)
*
|
2004-12-31 |
2013-12-10 |
Dr. Reddy's Laboratories Ltd. |
Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
|
CN103102303B
(zh)
*
|
2004-12-31 |
2015-10-28 |
雷迪博士实验室有限公司 |
作为cetp抑制剂的苄胺衍生物
|
EP1893178A1
(en)
|
2005-05-31 |
2008-03-05 |
Pfizer Products Incorporated |
PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG-CoA REDUCTASE INHIBITORS
|
CA2642130C
(en)
*
|
2005-12-28 |
2013-04-02 |
Reddy Us Therapeutics, Inc. |
Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
|
PE20071025A1
(es)
*
|
2006-01-31 |
2007-10-17 |
Mitsubishi Tanabe Pharma Corp |
Compuesto amina trisustituido
|
CA2641451C
(en)
|
2006-02-09 |
2012-10-02 |
Merck & Co., Inc. |
Polymer formulations of cetp inhibitors
|
WO2007128568A1
(en)
|
2006-05-10 |
2007-11-15 |
Novartis Ag |
Bicyclic derivatives as cetp inhibitors
|
US7790737B2
(en)
*
|
2007-03-13 |
2010-09-07 |
Kowa Company, Ltd. |
Substituted pyrimidine compounds and their utility as CETP inhibitors
|
JP4834699B2
(ja)
*
|
2007-07-30 |
2011-12-14 |
田辺三菱製薬株式会社 |
医薬組成物
|
CN101418397A
(zh)
*
|
2008-12-02 |
2009-04-29 |
西北有色金属研究院 |
一种TiB2强化的MgAlB14超硬材料的制备方法
|